Pyrrolidine

Pyrrolidine

SCHEMBL4931392

C1CCNC1.[C-]#[N+]CC(=O)N1CCCC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.42
CHKA P35790 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
ATM Q13315 1/20 0.41
NPC1 O15118 2/20 0.38
HPGD P15428 1/20 0.38
BIRC2 Q13490 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
ECE2 P0DPD6 1/20 0.33
RAB9A P51151 1/20 0.33
BPTF Q12830 1/20 0.33
DPP4 P27487 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL295163 0.88 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1ATMNPC1HPGD
SCHEMBL2696686 0.86 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1ATMNPC1HPGD
SCHEMBL24693081 0.73 CA2 (0.50) CA2CHKASMN1; SMN2ALDH1A1ATM
SCHEMBL4212544 0.72 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1ATMHPGDGAA
SCHEMBL4219173 0.71 FAAH (0.39) SMN1; SMN2ALDH1A1ATMNPC1HPGD
SCHEMBL2696781 0.71 L3MBTL1 (0.53) SMN1; SMN2ALDH1A1NPC1L3MBTL1POLB
SCHEMBL4216418 0.71 TDP1 (0.46) SMN1; SMN2L3MBTL1POLBKMT2ATDP1
Azepane SCHEMBL8788594 0.70 ATM (0.50) CA2CHKASMN1; SMN2ALDH1A1ATM
SCHEMBL4630198 0.70 CA2 (0.61) CA2CHKASMN1; SMN2ALDH1A1ATM
SCHEMBL4870186 0.69 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1NPC1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008109286-A1 METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS ALLERGAN, INC. (US) 2008-09-12 WO disclosed